The planned sites in Livonia, Las Vegas, and San Antonio would expand a partnership that places clinical research and health ...
The FDA’s RTCT initiative transmits predefined, clinically meaningful signals to regulators during active trials, so its value depends entirely on the maturity of sponsors’ upstream RBQM signal ...
In this video interview, Kent Thoelke, CEO of Paradigm Health, outlines why anti-kickback guidance and modern EHR-integrated ...
In today’s ACT Brief, we examine how legacy workflows pull community clinics away from patient care, why medical writing ...
Medical writing capacity pressure is fundamentally a talent development problem, not a technology problem, since hybrid ...
In this video interview, Kent Thoelke, CEO of Paradigm Health, describes how manual eligibility screening and swivel-chair ...
In today’s ACT Brief, we examine how cost barriers and site infrastructure limit participation in community trials, why ...
In this video interview, Kent Thoelke, CEO of Paradigm Health, explains why patient cost barriers and site infrastructure ...
Applied Clinical Trials is the thought leader in pharmaceutical drug development operations and clinical trial design, management, and monitoring.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results